Sai Life Sciences Limited has informed the Exchange regarding allotment of 19000 securities pursuant to ESOP/ESPS at its meeting held on Jun 09, 2025
SAILIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
On June 9, 2025, Sai Life Sciences' Board approved the allotment of 19,000 equity shares (face value Re. 1) to employees upon exercise of stock options. This includes 14,000 shares under the Management ESOP Plan 2018 at an exercise price of Rs 23.30 per share (realising Rs 3.26 lakh) and 5,000 shares under ESOP 2008 at Rs 188.90 per share (realising Rs 9.45 lakh). After this allotment, the company's total issued share capital stands at 208,505,073 equity shares. The shares are issued in dematerialised form with no lock-in period and are identical to existing shares.
This is a routine ESOP exercise disclosure with minimal dilution impact (19,000 shares out of over 20.85 crore outstanding shares). It signals normal employee stock option activity with no material effect on shareholders' value or stock price.